Crossmark

Effectiveness and safety of tralokinumab in a patient with severe atopic dermatitis and hepatitis B virus

Crossref DOI link: https://doi.org/10.1016/j.abd.2025.501239

Published Print: 2025-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Olivares-Guerrero, María https://orcid.org/0009-0003-0073-4039
Jiménez-Sánchez, Ana https://orcid.org/0009-0005-1665-1822
Aparicio-Domínguez, Mario

Chicharro, Pablo https://orcid.org/0000-0001-5153-4262
License Information

Text and Data Mining valid from 2025-11-01

Text and Data Mining valid from 2025-11-01

Version of Record valid from 2025-10-14
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness and safety of tralokinumab in a patient with severe atopic dermatitis and hepatitis B virus

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2025.501239

Content Type: article

Copyright: © 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.